Frazier Life Sciences Management L.P. Invests $15.76 Million in Dyne Therapeutics, Inc. (NASDAQ:DYN)

Frazier Life Sciences Management L.P. bought a new position in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,184,840 shares of the company’s stock, valued at approximately $15,758,000. Frazier Life Sciences Management L.P. owned 1.93% of Dyne Therapeutics at […]

Related Keywords

China ,United States ,Oxana Beskrovnaya ,Stifel Nicolaus ,Nasdaq ,Dyne Therapeutics Inc ,China Universal Asset Management Co ,Morgan Stanley ,Sg Americas Securities ,Frazier Life Sciences Management ,Jefferies Financial Group ,Corton Capital Inc ,Principal Financial Group Inc ,Profund Advisors ,Dyne Therapeutics ,Free Report ,Universal Asset Management ,Financial Group ,Gatti High ,Get Free Report ,Visit Holdingschannel ,Dyne Therapeutics Daily ,